Has this become a lifestyle company for the CEO and senior management? The new chairman ( appointed by the CEO) seems only interested in retaining the poorly performing management team. Negative return over 5 years, in what should have been the most exciting period ( post FDA approval). Surely it is time for a change. Enough of the lies and false promises.
looking forward to phi/parvismelanotide results Cy 23 as promised
Has this become a lifestyle company for the CEO and senior...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.23 |
Change
-0.010(0.07%) |
Mkt cap ! $764.0M | |||
| Open | High | Low | Value | Volume |
| $15.36 | $15.48 | $15.18 | $69.82K | 4.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 56 | $15.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 21 | 8 |
View Market Depth
| Last trade - 11.26am 28/06/2024 (20 minute delay) ? |
| CUV (ASX) Chart |